Is There Really a Benefit to Net Clinical Benefit in Testing Antithrombotics?
نویسندگان
چکیده
منابع مشابه
Is positive income elasticity of demand really associated with normal goods?: revisiting the Slutsky equation and net benefit ratio
Incorporating a household’s net sale status into a rearranged Slutsky equation with combined ordinary and endowment income effects, this paper aims to reinterpret the income elasticity of demand in the case of buying and selling and to associate it with types of goods in a novel manner. To this end, the Deaton’s (1989) net benefit ratio (NBR) approach is expressed as the difference between orig...
متن کاملIncremental net benefit in randomized clinical trials.
There are three approaches to health economic evaluation for comparing two therapies. These are (i) cost minimization, in which one assumes or observes no difference in effectiveness, (ii) incremental cost-effectiveness, and (iii) incremental net benefit. The latter can be expressed either in units of effectiveness or costs. When analysing data from a clinical trial, expressing incremental net ...
متن کاملIs there benefit in smoking cessation prior to cardiac surgery?
A best evidence topic was written according to a structured protocol. The question addressed was whether smoking cessation prior to cardiac surgery would result in a greater freedom from postoperative complications. A total of 564 papers were found using the reported searches, of which five represented the best evidence to answer the clinical question. The authors, date, journal, study type, po...
متن کاملDonations: how to ensure you really benefit
Why do things sometimes go wrong? Some of the causes are: • Inadequate communication between the donor of the equipment and the receiving eye unit, so that the eye unit ends up with an item which is not appropriate, is not robust, cannot be maintained, does not include spare parts or a manual, and which no-one knows how to use. • Failure to identify all the costs involved, such as training, shi...
متن کاملNet Clinical Benefit of Warfarin in Patients With Atrial Fibrillation
Background—Known risk factors for bleeding during anticoagulant treatment are largely the same as those predicting thromboembolic events in patients with atrial fibrillation (AF). Our objective was to investigate how to maximize the likelihood of avoiding both stroke and bleeding. Methods and Results—All 182 678 subjects with atrial fibrillation in the Swedish Hospital Discharge Register were s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2018
ISSN: 0009-7322,1524-4539
DOI: 10.1161/circulationaha.117.033442